These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4434064)

  • 1. Letter: The NSD concept and radioresistant tumours.
    Ellis F
    Br J Radiol; 1974 Dec; 47(564):909. PubMed ID: 4434064
    [No Abstract]   [Full Text] [Related]  

  • 2. [Morphological changes, scar status, and functional results of irradiated tumors].
    Veraguth P; Djelali D
    Schweiz Med Wochenschr; 1974 Feb; 104(8):287-94. PubMed ID: 4273571
    [No Abstract]   [Full Text] [Related]  

  • 3. The relationship of NSD to reactions and complications following treatment for malignant uterine cervical neoplasms.
    Buchler DA; Kline JC; Peckham BM; Ellis F
    Radiology; 1974 Mar; 110(3):687-90. PubMed ID: 4204517
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiotherapy of tumours by a dynamic dose-fractionation regime combined with oxygen inhalation (preliminary report of 20 cases of tumours localized to the head and neck and uterine cervix).
    Siracká E; Durkovský J; Jancina J; Révész L
    Neoplasma; 1971; 18(6):607-16. PubMed ID: 5160901
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical applicability of the NSD-concept--possibilities and limits].
    Herrmann T; Voigtmann L
    Radiobiol Radiother (Berl); 1979 Feb; 20(1):51-63. PubMed ID: 461733
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of radiotherapy of malignant neoplasms with fractionated doses].
    Zholkiver KI; Karibdzhanova ZB; Balmukhanov SB
    Med Radiol (Mosk); 1973 Jan; 18(1):73-81. PubMed ID: 4200135
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biological effectiveness of a course of cancer radiation therapy and ways to express it].
    Kholin VV; Frolova ZV
    Med Radiol (Mosk); 1972 Dec; 17(12):64-74. PubMed ID: 4618320
    [No Abstract]   [Full Text] [Related]  

  • 8. The dose rate factor from interstitial irradiation with 103-palladium and 109-palladium.
    Ariel IM; Robertson JS
    Surg Gynecol Obstet; 1971 May; 132(5):817-31. PubMed ID: 4325109
    [No Abstract]   [Full Text] [Related]  

  • 9. Morbidity from large dose fractions in radiotherapy.
    Peters LJ; Withers HR
    Br J Radiol; 1980 Feb; 53(626):170-1. PubMed ID: 7370507
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of multicellular spheroids in studies based on the NSD (nominal standard dose) concept].
    Ertsgreber G; Shmakova NL; Langrok K
    Radiobiologiia; 1984; 24(2):180-4. PubMed ID: 6729062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results and prospects of radiation therapy of malignant tumors].
    Pavlov AS
    Vestn Akad Med Nauk SSSR; 1982; (12):49-54. PubMed ID: 6818782
    [No Abstract]   [Full Text] [Related]  

  • 12. Determining optimum dose-time-area relationships in curative radiotherapy of cancer. A review and evaluation.
    Fichardt T
    S Afr Med J; 1973 Jun; 47(24):1070-80. PubMed ID: 4578604
    [No Abstract]   [Full Text] [Related]  

  • 13. [Optimization of the timing of dose distribution in radiation therapy].
    Kozlov AP; Afanas'ev BP; Antonevich OV; Akimov AA
    Med Radiol (Mosk); 1985 Jun; 30(6):49-52. PubMed ID: 4021753
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Optimal radiotherapy of radioresistant tumours.
    Wheldon TE; Kirk J
    Br J Radiol; 1975 Oct; 48(574):870-1. PubMed ID: 1191910
    [No Abstract]   [Full Text] [Related]  

  • 15. Methods for extracting dose response curves from radiation therapy data, I: a unified approach.
    Herring DF
    Int J Radiat Oncol Biol Phys; 1980 Feb; 6(2):225-32. PubMed ID: 7406966
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ratio of the optimal therapeutic dose to the number of fractions and the volume of the irradiated tumor].
    Kholin VV; Bartova VF
    Med Radiol (Mosk); 1981 Apr; 26(4):46-8. PubMed ID: 7231067
    [No Abstract]   [Full Text] [Related]  

  • 17. [How tolerant are partial dose values? Some additional remarks on the concept of a tolerance dose].
    Jensen JM; Melchert UH; Ihnen E
    Strahlenther Onkol; 1992 Nov; 168(11):640-5. PubMed ID: 1455292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of high activity cobalt 60 sources for intracavitary and surface mould therapy.
    Joslin CA; Smith CW
    Proc R Soc Med; 1970 Oct; 63(10):1029-34. PubMed ID: 5483502
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical examinations of different fractionation rhythms for radiation therapy. Fractionation studies by means of CRE-function].
    Notter G; Ragnhult I; Turesson I
    Radiobiol Radiother (Berl); 1975; 16(4):425-35. PubMed ID: 1208826
    [No Abstract]   [Full Text] [Related]  

  • 20. Re-assessment of normalization between fractionated and continuous radiotherapy for the CRE and TDF equations.
    Orton CG
    Br J Radiol; 1980 Apr; 53(628):374-5. PubMed ID: 7378710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.